MIODx® is using its custom ClonoMap platform to profile an individual’s adaptive immune system over time. The ultimate goal is to use T cell diversity as a prognostic tool to improve medical outcomes.
Thermo Fisher Scientific
286 followers
Illumina
93 followers
Guardant Health
17 followers
AbbVie
360 followers
Moderna Therapeutics
142 followers
Elanco
39 followers
Emet Digital
2 followers
Genentech
227 followers
Gilead Sciences
215 followers
Regeneron
184 followers
Biogen
167 followers
Vertex Pharmaceuticals
111 followers